Skip to content

Treatment of depression by integration of Homeopathy to conventional Medicine

The Effect of add on therapy of ultra-high dilution Natrium muriaticum on Depression and Quality of Life of depressed patients in comparison with placebo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013011912175N1
Enrollment
40
Registered
2013-09-05
Start date
2012-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive episode. The patient suffers of depressed mood, low energy and decreased activity.

Interventions

Intervention 1: Group 1 = Homeopathy Main remedy is Natrium muriaticum 30CH & 200CH (every two weeks) 5-20 cc Company
Helios (UK). Intervention 2: Group2 = Placebo = Water.
Treatment - Drugs
Placebo
Group 1 = Homeopathy Main remedy is Natrium muriaticum 30CH & 200CH (every two weeks) 5-20 cc Company
Helios (UK)
Group2 = Placebo = Water

Sponsors

Isfahan university of Medical sciences, Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
37 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 18 and 65. Depress patients. Do not have history of drug anaphylaxis. Do not have psychosis. Do not suffer from neurological or rheumatic treatment such as Multiple Sclerosis (MS), Vasculitis etc. Do not have cancer nor receive chemotherapy Match their symptoms with core dynamism of Natrium muriaticum Not receive alternative medicine such as herbal medicine and acupuncture in the last month

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression severity. Timepoint: Before and After 6 months of treatment. Method of measurement: The Beck Depression Inventory (BD II),.

Secondary

MeasureTime frame
Quality of life. Timepoint: After 6 months of treatment. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Mahmoudian

Isfahan University of Medical Sciences

a_mahmoudian@med.mui.ac.ir+98 31 1792 2510

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026